Communities

Drug Safety Communications - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.

Pahola

Pahola is PAHO's first artificial intelligence (AI) health specialist and the only AI digital health worker in the world that specializes in alcohol-related topics. Pahola can communicate interactively - in three languages (English, Portuguese, and Spanish) - with people about their alcohol consumption, assess their risk, help them reduce or stop alcohol use, or direct them to resources for treatment and recovery

Treatment for Individuals who Use Stimulants (TRUST) Clinician Manual and Patient Workbook

A Protocol using empirically-supported behavioral treatments for people with psychoactive stimulant use disorders. There are manuals for healthcare professionals who provide treatment services for individuals with psychoactive substance use disorder (PSUD) and for patients who are entering PSUD treatment.